BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Latest News
20:53
Ynet: US intends to reach deal with Iran by April 9
Other countries20:42
Iranian Parliament Speaker Ghalibaf leading talks with US
Other countries20:31
Iranian parliament sees no point in negotiations with US
Region20:21
Azerbaijan's iodine production falls by 0.7% in early 2026
Industry20:04
France: Leftist Emmanuel Gregoire becomes new mayor of Paris
Other countries19:58
Photo
Azerbaijan's taekwondo athletes win six medals in Belgium
Individual sports19:33
Fidan and Ishaq Dar discuss Trump's statement on halting operations against Iran
Region19:12
Photo
Novruz holiday celebrated in Strasbourg with vibrant mugham concert
Foreign policy18:55